;

Statistics for Kiniksa Pharmaceuticals Ltd (id:7861 KNSA)


Valuation metrics

Market cap
1.48B
Enterprise value
1.27B
Trailing P/E (ttm)
164.31
Forward P/E
37.29
PEG ratio
37.29
Price/Sales (ttm)
3.86
Price/Book (mrq)
3.39
Enterprise Value/Revenue
3.30
Enterprise Value/EBITDA
-51.89

Overview

Shares outstanding
41.57M
Float
15.29M
Shares short
4.02M
% Held by insiders
5.00%
% Held by institutions
3.00%
Average volume (10 days)
261.34K
Average volume (90 days)

Price summary

52-Week low
16.56
52-Week high
28.15
52-Week change
9.66%
Beta
3.00
50-Day moving average
22.97
200-Day moving average
21.91

Dividends and splits

Forward annual dividend rate
Forward annual dividend yield
Trailing annual dividend rate
0.00%
Trailing annual dividend yield
0.00
5-Year annual dividend yield
Payout ratio
0.00
Dividend date
Ex-dividend date
Last split factor
2:1
Last split date

Financials

Fiscal year
Fiscal year ends
December 31, 2023
Most recent quarter (mrq)
September 30, 2024
Profitability
Profit margin
-2.36%
Operating margin
-8.61%
Operational effectiveness
Return on assets
-3.16%
Return on equity
-2.15%
Income statement
Revenue (ttm)
5.42
Revenue per share (ttm)
5.42
Quarterly revenue growth (yoy)
3.00
Gross profit (ttm)
236.85M
EBITDA
-24,401,000.00
Net income to common (ttm)
-9,068,000.00
Diluted EPS (ttm)
3.00
Quarterly earnings growth (yoy)
67.37%
Balance sheet
Total cash (mrq)
223.78M
Total cash per share (mrq)
3.10
Total debt (mrq)
10.60M
Total Debt/Equity (mrq)
2.42
Current ratio (mrq)
324.40%
Book value per share (mrq)
6.06
Cash flow
Cash flow statement
11.24M
Levered free cash flow (LFCF)
25.74M

CleverShares.com|
2024 ©

1.0.9119.29486